Intervention Review

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

  1. Cathie LM Sudlow1,*,
  2. Gillian Mason2,
  3. James B Maurice3,
  4. Catherine J Wedderburn3,
  5. Graeme J Hankey4

Editorial Group: Cochrane Stroke Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 12 JUL 2009

DOI: 10.1002/14651858.CD001246.pub2


How to Cite

Sudlow CLM, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001246. DOI: 10.1002/14651858.CD001246.pub2.

Author Information

  1. 1

    University of Edinburgh, Division of Clinical Neurosciences, Edinburgh, UK

  2. 2

    Maroondah Hospital, Melbourne, Victoria, Australia

  3. 3

    University of Edinburgh, College of Medicine and Veterinary Medicine, Edinburgh, UK

  4. 4

    Royal Perth Hospital, Department of Neurology, Perth, Western Australia, Australia

*Cathie LM Sudlow, Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. cathie.sudlow@ed.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH